Revolutionizing Vaccinations: Pune-Based Firm Introduces Needle-Free Injection System
A Pune-based company, IntegriMedical, has developed a needle-free injection system (N-FIS) that promises to make vaccinations painless and stress-free for children and adults alike.
Needlefree InjectionVaccinationIntegrimedicalHealthcare InnovationPainless InjectionReal Estate PuneJun 05, 2025
“It was like magic,” says the child’s parents. “The little girl is usually scared of needles, but here, she just slept throughout.”
And Mutha is overjoyed. “It’s a significant milestone for us,” he says. “Our goal was to make the vaccination process as comfortable and stress-free as possible, and seeing it work so effectively is incredibly rewarding.”
IntegriMedical, based in Pune, has been at the forefront of developing innovative medical solutions. The company’s N-FIS uses a high-pressure jet to deliver medication through the skin without the need for a needle. This technology not only eliminates the pain and fear associated with traditional injections but also reduces the risk of needlestick injuries and infections.
The development of the N-FIS was driven by a combination of advanced engineering and a deep understanding of patient needs. Mutha, a biomedical engineer, and his team spent years researching and testing various methods to ensure the system was both safe and effective. “We conducted extensive clinical trials and gathered feedback from healthcare professionals and patients to refine our technology,” Mutha explains.
The N-FIS has already been approved by regulatory bodies in India and is currently being used in several healthcare facilities across the country. The response from the medical community has been overwhelmingly positive. Dr. Anjali Sharma, a pediatrician in Mumbai, says, “The needle-free injection system has been a game-changer in our practice. Parents are more willing to bring their children for vaccinations, and the overall experience is much more pleasant.”
The potential applications of the N-FIS extend beyond pediatric care. It can be used for various medical procedures, including insulin injections for diabetes patients and vaccine administration for adults. IntegriMedical is also exploring the possibility of expanding its reach to other countries and collaborating with global health organizations.
While the company is proud of its achievements, Mutha and his team remain committed to continuous improvement. “We are constantly working on enhancing the technology and making it more accessible to people in remote and underserved areas,” he says. “Our ultimate goal is to contribute to a healthier world by making medical treatments more comfortable and effective.”
The success of the N-FIS is a testament to the power of innovation and the positive impact it can have on people’s lives. As IntegriMedical continues to push the boundaries of medical technology, the future of healthcare looks brighter and more promising than ever.
Frequently Asked Questions
What is a needle-free injection system (N-FIS)?
A needle-free injection system (N-FIS) is a medical device that uses a high-pressure jet to deliver medication through the skin without the need for a needle. This technology is designed to make the injection process painless and less stressful for patients.
Who developed the N-FIS?
The N-FIS was developed by IntegriMedical, a Pune-based company led by biomedical engineer Sarvesh Mutha. The company has been at the forefront of developing innovative medical solutions to improve patient care.
How does the N-FIS work?
The N-FIS works by using a high-pressure jet to propel a fine stream of medication through the skin. This method ensures that the medication is delivered accurately and efficiently, without the need for a needle, thus reducing pain and fear associated with traditional injections.
What are the benefits of using the N-FIS?
The N-FIS offers several benefits, including painless and stress-free injections, reduced risk of needlestick injuries and infections, and improved patient compliance. It is particularly beneficial for children and adults who are afraid of needles.
Where is the N-FIS currently being used?
The N-FIS has been approved by regulatory bodies in India and is currently being used in several healthcare facilities across the country. IntegriMedical is also exploring the possibility of expanding its reach to other countries and collaborating with global health organizations.
Related News Articles
Baba Siddique: From Mumbai’s Streets to the Halls of Power and Bollywood
Baba Siddique, a prominent figure in Mumbai’s political and social circles, built a career that spanned local politics, real estate, and Bollywood. Known for his influential connections and ability to navigate power structures, Siddique’s life and controv
Godrej Properties Expands Rapidly Despite Rising Debt: Focus on Growth
Godrej Properties, a major player in the Indian real estate market, is set to raise significant funds to fuel its expansion plans in key cities like Delhi-NCR, Mumbai, Pune, and Bengaluru.
Haryana Real Estate Regulatory Authority Directs Anant Raj Builders to Pay Interest and Execute Conveyance Deed
In a landmark decision, the Haryana Real Estate Regulatory Authority (Haryana RERA) has ordered Anant Raj Builders to pay interest and execute a conveyance deed in favor of a homebuyer. This move is seen as a significant step towards protecting the rights
Mumbai Records ₹896 Crore in Stamp Duty from 11,541 Property Registrations in February
Mumbai's property market remained robust in February, with 11,541 sale registrations contributing to a significant ₹896 crore in stamp duty revenue. The continued surge in property transactions reflects the city's resilience and strong demand in the real
Cyber Fraud in Pune: Accountant Trickery Leads to Rs 1.9 Crore Loss
In a sophisticated whale phishing scam, a Pune-based real estate company's accountant was duped into transferring Rs 1.9 crore to fraudulent accounts. This incident highlights the growing threat of cybercrime in the real estate sector.
Private Equity Investments in Indian Real Estate Dip 3% to $3.7 Billion in FY25
Private equity investments in the Indian real estate sector witnessed a 3% decline, amounting to $3.7 billion in the fiscal year 2024, as per the latest report by Anarock. The decrease is attributed to reduced fund inflows and a cautious investment landscape.